Global Rating of Change Scale
- Introduced by
- Ruben Jaeschke, Jack Singer, Gordon H. Guyatt
- Year
- 1989
- Type
- Patient global perception
- Family
- global-outcome-anchoring
What does it do?
The Global Rating of Change (GRC) Scale is a single-item, self-report outcome measure that asks patients to rate the overall change in their condition since baseline assessment.
Developed by Jaeschke, Singer, and Guyatt in 1989 and published in Controlled Clinical Trials, the GRC Scale has become a fundamental method for anchor-based interpretation of change scores on clinical outcome measures, enabling clinicians and researchers to determine the minimal clinically important difference (MCID) in standardized scales.
The intuition behind the method
While standardized outcome measures (e.g., LEFS, IKDC) quantify functional change, the GRC Scale captures the patient's overall subjective perception of improvement or deterioration—the 'big picture' question: 'How much has your condition changed overall?' The GRC typically uses a 15-point scale (−7 to +7, with 0 = no change), where negative values indicate worsening, zero indicates no change, and positive values indicate improvement. The brilliance of the GRC is its use as an external 'anchor': patients also complete standardized outcome measures, and the relationship between GRC scores and changes on standardized measures reveals the minimal clinically important difference (MCID). A GRC score of +2 or +3 typically corresponds to 'a little bit better' or 'somewhat better' perceived improvement; the change in standardized measures at this GRC threshold defines the MCID for that measure.
History
The Global Rating of Change Scale was introduced by Jaeschke, Singer, and Guyatt in 1989 in Controlled Clinical Trials as a methodological tool for anchor-based determination of the minimal clinically important difference (MCID). This landmark paper established the GRC approach and its use in interpreting change on standardized outcome measures. While the concept of asking patients about overall change is simple and likely used informally for decades, Jaeschke and colleagues formalized the method and demonstrated its validity for MCID studies. The GRC has since become a standard methodology in health outcomes research, used in thousands of studies to define MCID for standardized measures across medical specialties.
When to use it
The GRC Scale is indicated in two primary contexts: (1) Clinical practice: simple patient assessment of overall change; useful for quick outcome assessment in busy clinics; rapid communication of patient perception to clinicians. (2) Research: essential for anchor-based MCID studies, where standardized outcome measures are administered alongside GRC to determine what change score on a standardized measure corresponds to clinically meaningful improvement. GRC is also used in comparative effectiveness trials where overall patient perception of benefit is the research question. GRC is NOT a substitute for standardized outcome measures; it complements them by providing an external anchor for interpreting standardized measure scores.
Limitations and considerations
- Single item provides only global perception without detail on which specific domains improved (pain? function? stability?); does not identify cause of improvement.
- Subject to recall bias and response-shift bias; patients' memory of baseline status and internal recalibration of health expectations can influence GRC ratings.
- Ordinal scale (not interval); statistical analysis is limited to non-parametric methods (median, rank tests); does not allow meaningful arithmetic operations (e.g., averaging multiple patients' GRC scores).
- GRC cutoff for 'meaningful improvement' (typically ≥+2 or ≥+3) may vary across conditions and populations; no universal threshold applies to all studies.
Source conditions do not replace independent scientific review or validation by an analysis engine.
Strengths
- Extremely simple and brief (single item, <1 minute); low respondent burden; no clinician training required; applicable across all patient populations and conditions.
- Direct measure of patient perception of change; patients' subjective global impression is often the most clinically relevant outcome; responsive to clinically meaningful change.
- Invaluable for anchor-based MCID determination; enables translation of standardized measure change scores into patient-meaningful terms.
- Free, no copyright restrictions; widely available; extensively used in health outcomes research, enabling interpretation of standardized measure changes across studies.
Applications
- Anchor-based MCID determination: pairing GRC with standardized outcome measures (LEFS, IKDC, FAOS) to establish what change score represents 'a little better' or 'moderately better' patient perception; foundational for interpreting standardized measure responses.
- Clinical outcome monitoring: simple patient perception of overall change; useful in busy clinical settings for rapid assessment of treatment benefit.
- Comparative effectiveness trials: primary outcome in studies where overall patient perception of benefit is the key research question; enables comparison across treatment arms on a patient-perceived change metric.
- Validation of new outcome measures: GRC serves as an external anchor to validate responsiveness and MCID of newly developed standardized scales.
- Patient satisfaction and shared decision-making: GRC ratings inform discussions with patients about progress; GRC ≥+2 reinforces benefit, while GRC ≤−2 signals need for treatment adjustment.
How it works
How it works
At follow-up (e.g., 2 weeks, 4 weeks, 6 weeks post-baseline), the patient is asked a single global question: 'How would you rate the overall change in your condition since you first came to the clinic?' or 'Compared to when you started treatment, how would you rate your improvement?' The patient selects a response on a 15-point ordinal scale: −7 = very much worse, −6 = much worse, −5 = moderately worse, −4 = somewhat worse, −3 = a little worse, −2 = slightly worse, −1 = almost the same (slightly worse), 0 = about the same, +1 = almost the same (slightly better), +2 = slightly better, +3 = a little better, +4 = somewhat better, +5 = moderately better, +6 = much better, +7 = very much better. Administration is simple: verbal question with response anchors provided on a card or printed scale. Time: <1 minute.
The GRC Scale is scored directly as a single value from −7 to +7. No transformation or subscale computation is needed. Responses are typically categorized for analysis: Worsening: −7 to −2; No change: −1 to +1; Improvement: +2 to +7 (with finer distinctions: minimal improvement +2 to +3, moderate improvement +4 to +5, substantial improvement +6 to +7). Alternatively, some researchers use dichotomous classification: 'improved' (GRC ≥+2) vs. 'not improved' (GRC <+2). For anchor-based MCID studies, the relationship between GRC category and change in standardized measures (e.g., LEFS, IKDC) is plotted, typically using receiver-operating-characteristic (ROC) analysis or mean change scores at each GRC level.
GRC score interpretation depends on clinical context and use: (1) For individual patient monitoring: GRC ≥+2 indicates 'a little better' or greater improvement (clinically meaningful); GRC +1 to −1 indicates minimal or no perceived change; GRC ≤−2 indicates worsening. (2) For anchor-based MCID determination: mean change in standardized measures (e.g., LEFS) at GRC threshold of +2 or +3 defines the MCID. For example, if patients with GRC = +2 (slightly better) show an average LEFS improvement of 9 points, then MCID of LEFS ≈ 9 points. GRC cutoff of ≥+2 is most common for defining 'meaningful improvement,' though some instruments or populations support ≥+3.
Common pitfalls
- Using GRC as the sole outcome measure in research; GRC alone does not quantify magnitude of change across domains. Always pair GRC with standardized outcome measures.
- Administering GRC at baseline (time 0); GRC is only meaningful at follow-up when change has occurred. GRC at baseline is meaningless (always 0).
- Failing to standardize the GRC question wording or scale presentation; slight variations in question wording (e.g., 'improvement' vs. 'change') or response anchors can influence responses. Use standardized, validated GRC wording.
- Interpreting GRC as absolute outcome level rather than change; GRC ≥+2 does not mean 'excellent function,' only 'meaningful improvement.' Distinguish between outcome level (absolute status) and outcome change (GRC).
Frequently asked questions
What is the relationship between GRC and MCID?
GRC is used to determine MCID. Patients rate their overall change (GRC −7 to +7) and complete standardized outcome measures at the same time point. The change score on the standardized measure is then linked to GRC categories: researchers identify the GRC threshold that represents 'a little better' improvement (typically GRC ≥+2 or ≥+3) and calculate the corresponding mean change on the standardized measure. This mean change = the MCID. For example, LEFS MCID of 9 points was derived from studies showing that patients rating GRC = +2 or +3 had an average LEFS change of ~9 points.
Can I use GRC as my only outcome measure in a randomized controlled trial?
Not recommended. GRC alone provides global patient perception but lacks specificity regarding which domains improved (pain? function? swelling?). Use GRC as one outcome among several standardized measures (LEFS, IKDC, pain scale, ROM). GRC is particularly useful as an anchor for interpreting changes in standardized measures.
What GRC cutoff score indicates 'clinically important improvement'?
Most commonly, GRC ≥+2 ('slightly better' or greater) is considered clinically important improvement. Some studies use ≥+3 ('a little better'). The choice depends on your study population and condition; more conservative populations may require higher threshold (≥+3). Specify your chosen cutoff a priori in research protocols.
How should I handle GRC responses that seem inconsistent with standardized measure change?
Occasional inconsistency is expected (response-shift, recall bias, individual variation). Analyze group-level relationships between GRC and standardized measures (ROC curves, mean change at each GRC level) rather than expecting perfect individual correspondence. Document any outliers (e.g., patient reports GRC +5 but LEFS decreased by 5 points) and investigate reasons (contextual improvements not captured by standardized measures).
Related methods
Sources
Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407-415.
Open DOI referenceCopied.